DekaBank Deutsche Girozentrale’s Zentalis Pharmaceuticals ZNTL Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio ZNTL Stock Details ZNTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-15,050	Closed	-$408K	–	1444
2022 Q2	$408K	Hold	15,050	–	–	﹤0.01%	1056
2022 Q1	$686K	Buy	15,050 +1,400	+10%	+$75.5K	﹤0.01%	996
2021 Q4	$1.14M	Buy	13,650 +350	+3%	+$27.1K	﹤0.01%	912
2021 Q3	$818K	Hold	13,300	–	–	﹤0.01%	945
2021 Q2	$707K	Hold	13,300	–	–	﹤0.01%	988
2021 Q1	$536K	Hold	13,300	–	–	﹤0.01%	1016
2020 Q4	$725K	Buy	+13,300	New	+$600K	﹤0.01%	942

Other funds holding ZNTL

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

Tybourne Capital Management Hong Kong $30.9M AUM 20.1% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

DekaBank Deutsche Girozentrale's ZNTL Position: Q3 2022 in Review

DekaBank Deutsche Girozentrale sold out of Zentalis Pharmaceuticals (ZNTL) in Q3 2022, closing a stake of 15,050 shares — an estimated $408K sold.

DekaBank Deutsche Girozentrale first reported a position in ZNTL in Q4 2020 and held it in 7 quarters. The position peaked at $1.14M in Q4 2021. 120 funds tracked by Wall St. Rank hold ZNTL as of Q3 2022.

DekaBank Deutsche Girozentrale reported no remaining Zentalis Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 15,050 Zentalis Pharmaceuticals shares in Q3 2022, an estimated $408K.
DekaBank Deutsche Girozentrale first reported a position in Zentalis Pharmaceuticals in Q4 2020 and held it in 7 quarters.
DekaBank Deutsche Girozentrale's Zentalis Pharmaceuticals position peaked at $1.14M in Q4 2021.
120 funds tracked by Wall St. Rank held Zentalis Pharmaceuticals as of Q3 2022.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q3 2022, filed 2 Nov 2022.